Filing Flows › AdaptHealth (AHCO) › Q2 2026 › vs Q2 2025
AdaptHealth (AHCO) Q2 2026 vs Q2 2025 (year over year)
AdaptHealth's revenue rose $83.2M (+13%) from $657M in Q2 2025 to $740M in Q2 2026. The biggest changes: Sleep Health +$51.8M (+15%); Respiratory Health +$24.0M (+14%); Wellness at Home +$7.5M (+5%).
AdaptHealth, Q2 2026: revenue $740M (+13% year over year), operating margin -18.6%, net loss $133M, operating cash flow $145M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Sleep Health | $386M | $335M | $51.8M | +15% |
| Respiratory Health | $194M | $170M | $24.0M | +14% |
| Wellness at Home | $159M | $152M | $7.5M | +5% |
| Revenue | $740M | $657M | $83.2M | +13% |
| Income tax benefit | $21.2M | −$32.8M | $54.0M | — |
| Net loss | $133M | −$15.8M | $149M | — |
| Costs & expenses | $894M | $657M | $237M | +36% |
| Operating costs | $878M | $591M | $287M | +48% |
| Interest & other, net | $16.1M | $17.1M | −$942K | -6% |
| Operating cash sources | $278M | $146M | $132M | +90% |
| Depreciation & amortization | $120M | $92.4M | $27.9M | +30% |
| Share-based compensation | $5.6M | $6.1M | −$574K | -9% |
| Working capital & other | $152M | $47.7M | $104M | +219% |
| Net loss absorbed | $133M | −$15.8M | $149M | — |
| Operating cash flow | $145M | $162M | −$16.7M | -10% |
| Capital expenditures | $166M | $88.7M | $77.6M | +87% |
| Negative free cash flow (OCF − capex) | $20.9M | −$73.3M | $94.3M | — |
Questions
How much did AdaptHealth's revenue grow year over year in Q2 2026?
AdaptHealth's revenue rose $83.2M (+13%) from $657M in Q2 2025 to $740M in Q2 2026.
What drove AdaptHealth's revenue change in Q2 2026?
Sleep Health +$51.8M (+15%); Respiratory Health +$24.0M (+14%); Wellness at Home +$7.5M (+5%).